1.

What Should One Expect During A Clinical Trial?

Answer»

For all types of trials, participants work with a research or clinical trial team, including doctors, nurses, social workers, and other health care professionals. Prior to the trial, the research team will check the health of the PARTICIPANT and review any special instructions for trial participation. As the trial begins and THROUGHOUT its duration, the research team will administer treatment, (whether that be the experimental treatment, a standard treatment or a placebo depending on the requirements of the study) and monitor the participant on a regular basis to determine effectiveness and side-effects of the treatment.

Ongoing communication is an important part of any clinical trial and after the trial has been completed the research team will stay in touch with the participant for a specified period of time to ASSESS any effects of the treatment after treatment has stopped. The data collected before, during and after the trial is a crucial component to the drug’s APPROVAL SUBMISSION to drug regulatory agencies.

For all types of trials, participants work with a research or clinical trial team, including doctors, nurses, social workers, and other health care professionals. Prior to the trial, the research team will check the health of the participant and review any special instructions for trial participation. As the trial begins and throughout its duration, the research team will administer treatment, (whether that be the experimental treatment, a standard treatment or a placebo depending on the requirements of the study) and monitor the participant on a regular basis to determine effectiveness and side-effects of the treatment.

Ongoing communication is an important part of any clinical trial and after the trial has been completed the research team will stay in touch with the participant for a specified period of time to assess any effects of the treatment after treatment has stopped. The data collected before, during and after the trial is a crucial component to the drug’s approval submission to drug regulatory agencies.



Discussion

No Comment Found